Information

Diabetics don't have to worry about losing weig...

When diabetes meets obesity, how to solve the double challenge? For patients with type 2 diabetes, obesity and blood sugar control are often two major problems. Studies have shown that...

Diabetics don't have to worry about losing weig...

When diabetes meets obesity, how to solve the double challenge? For patients with type 2 diabetes, obesity and blood sugar control are often two major problems. Studies have shown that...

Why is Tesiparatide called the "magic drug for ...

Why is Tesiparatide called the "magic drug for diabetes" ? Analysis of three breakthrough advantages: 1. Revolutionary mechanism: dual targets to precisely regulate blood sugar. 2. Clinical data crushes traditional...

Why is Tesiparatide called the "magic drug for ...

Why is Tesiparatide called the "magic drug for diabetes" ? Analysis of three breakthrough advantages: 1. Revolutionary mechanism: dual targets to precisely regulate blood sugar. 2. Clinical data crushes traditional...

A guide to coping with oral semaglutide side ef...

As a revolutionary drug for reducing blood sugar and weight, semaglutide has significant effects, but many patients will encounter various side effects in the early stage of medication. We have...

A guide to coping with oral semaglutide side ef...

As a revolutionary drug for reducing blood sugar and weight, semaglutide has significant effects, but many patients will encounter various side effects in the early stage of medication. We have...

How to relieve dizziness and drowsiness by taki...

Lemborexant (trade name Dayvigo) is a new insomnia treatment drug approved in recent years. It works by selectively blocking the receptors of the wakefulness-promoting neuropeptide orexin. As a new mechanism...

How to relieve dizziness and drowsiness by taki...

Lemborexant (trade name Dayvigo) is a new insomnia treatment drug approved in recent years. It works by selectively blocking the receptors of the wakefulness-promoting neuropeptide orexin. As a new mechanism...

Four key ways to improve the efficacy of GLP-1 ...

The latest data shows that the effectiveness of GLP-1 drugs in actual use is often only half of that in clinical trials. Under ideal conditions, tebuconazole can achieve 20% weight...

Four key ways to improve the efficacy of GLP-1 ...

The latest data shows that the effectiveness of GLP-1 drugs in actual use is often only half of that in clinical trials. Under ideal conditions, tebuconazole can achieve 20% weight...

Tipoline approved in China: the world's first d...

Obstructive sleep apnea (OSA) is a chronic disease characterized by repeated nocturnal apnea. About 425 million people worldwide suffer from it, of which 176 million are in China. For a...

Tipoline approved in China: the world's first d...

Obstructive sleep apnea (OSA) is a chronic disease characterized by repeated nocturnal apnea. About 425 million people worldwide suffer from it, of which 176 million are in China. For a...